tiprankstipranks
Renalytix AI Plc (GB:RENX)
LSE:RENX

Renalytix AI (RENX) Share Price & Analysis

1 Followers

RENX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range10.00p - 150.00p
Previous Close30p
Volume47.27K
Average Volume (3M)730.02K
Market Cap
£37.87M
Enterprise Value40.17M
Total Cash (Recent Filing)$5.62M
Total Debt (Recent Filing)$8.48M
Price to Earnings (P/E)-0.9
Beta2.29
Jun 11, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding99,930,156
10 Day Avg. Volume223,941
30 Day Avg. Volume730,021
Standard Deviation0.27
R-Squared0.07
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)-5.18
Price to Sales (P/S)199207.17
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.85
Enterprise Value/Gross Profit55.79
Enterprise Value/Ebitda-1.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

24.48%0.00%0.13%75.40%
24.48% Insiders
0.13% Other Institutional Investors
75.40% Public Companies and
Individual Investors

RENX FAQ

What was Renalytix AI Plc’s price range in the past 12 months?
Renalytix AI Plc lowest share price was 10.00p and its highest was 150.00p in the past 12 months.
    What is Renalytix AI Plc’s market cap?
    Currently, no data Available
    When is Renalytix AI Plc’s upcoming earnings report date?
    Renalytix AI Plc’s upcoming earnings report date is Jun 11, 2024 which is in 48 days.
      How were Renalytix AI Plc’s earnings last quarter?
      Renalytix AI Plc released its earnings results on Feb 15, 2024. The company reported -0.036p earnings per share for the quarter, the consensus estimate of -0.036p by 0p.
        Is Renalytix AI Plc overvalued?
        According to Wall Street analysts Renalytix AI Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Renalytix AI Plc pay dividends?
          Renalytix AI Plc does not currently pay dividends.
          What is Renalytix AI Plc’s EPS estimate?
          Renalytix AI Plc’s EPS estimate is -£0.04.
            How many shares outstanding does Renalytix AI Plc have?
            Renalytix AI Plc has 126,219,020 shares outstanding.
              What happened to Renalytix AI Plc’s price movement after its last earnings report?
              Renalytix AI Plc reported an EPS of -0.036p in its last earnings report, expectations of -0.036p. Following the earnings report the stock price went down -29.67%.
                Which hedge fund is a major shareholder of Renalytix AI Plc?
                Currently, no hedge funds are holding shares in GB:RENX
                ---

                Renalytix AI Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Company Description

                Renalytix AI Plc

                Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
                ---

                RENX Earnings Call

                Q1 2023
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Renalytix AI
                Veracyte
                Natera
                Apellis Pharmaceuticals
                Avid Bioservices
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis